Hunter syndrome (MPS II) presentations will include analysis from continued follow-up of Phase 1/2 data for tividenofusp alfa (DNL310), currently under FDA Priority Review Preliminary data from Phase ...

Following the presentations, the data presented will be available on the Publications page, located within the Pipeline section, of the Company’s website at www ...

Love Data Week was established in 2016. What was originally created in the US quickly grew to an international event in which a wide range of institutions, organizers, scholars, students and data ...

TARRYTOWN, N.Y., Feb. 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: REGN) today announced upcoming presentations from its ophthalmology portfolio and pipeline at the virtual Angiogenesis (Angiogenesis, ...

The Indianapolis City-County Council Environmental Sustainability Committee met Wednesday evening for the sole purpose of discussing data center development in Indianapolis ...

Artiva Biotherapeutics is working on NK cell-based immunotherapy to treat autoimmune disease. Their lead project is an unmodified, preserved NK product that seeks to address challenges posed for CAR T ...

A browser editor that actually holds up ...

United Way’s footprint don’t earn enough, despite working at least one job, to afford the essentials of living. Financial ...

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented at ...